Bioanalysis accepted for coverage by ISI
Bioanalysis accepted for coverage by ISI
Future Science Ltd announces that its journal Bioanalysis (ISSN 1757-6180) has been selected for coverage by ISI: Science Citation Index Expanded®, available as the Web of Science®, Biosis Previews®, & Biosis Reviews Reports and Meetings®.
Maintained by Thomson Scientific, ISI (Institute for Scientific Information) offers bibliographic databases covering thousands of academic journals, including a continuation of its longtime print-based indexing service the Science Citation Index (SCI), as well as the Social Sciences Citation Index (SSCI), and the Arts and Humanities Citation Index (AHCI). All of these are available via ISI's Web of Knowledge database service. This database allows a researcher to identify which articles have been cited most frequently, and who has cited them.
Bioanalysis is published on a monthly (soon to increase to fortnightly from January 2011) basis in print and online formats on a rapid publication basis, with articles subject to peer review by three independent assessors. The journal has an international expert authorship and offers commentary and analysis on the advances, implementation and performance of analytical technologies.
Coverage of the journal is directed by two Senior Editors and an extensive international advisory panel. The two Senior Editors are Brian Booth, Deputy Director, US FDA, Division of Clinical Pharmacology 5, USA and Howard Hill, Group Director Pharmaceutical Development, Huntingdon Life Sciences, UK.
Howard Hill commented, “This is great news for the bioanalytical community. Bioanalysis fills an unmet niche and with wider coverage provided by Thomson Scientific it will truly globalize its appeal. Bioanalysis will play a major role in the harmonization of both regulatory guidelines and science in the field of bioanalysis.”
Elisa Manzotti, Editorial Director of the Future Science series commented, “This specialized field has emerged as a real focus of attention in the past few years. We are delighted that Bioanalysis has been accepted for inclusion and will work with the Senior Editors of the journal to ensure that future issues of Bioanalysis keep pace with the huge amount of research being generated.” She continued: “We would like to thank our Senior Editors and Editorial Board for their hard work, intellectual input and guidance in targeting and evaluating topical, pioneering content to ensure inclusion of the journal by ISI.”
Access to Bioanalysis is available on a FREE 30-day trial basis. To apply for your free trial please email info@future-science.com quoting reference BIO1010 to obtain password access.
--ENDS--
For further information please contact:
Craig Canham, Corporate Public Relations, Future Science Group
T: +44 (0) 20 8371 6092, F: +44 (0) 20 8343 2313, E: c.canham@future-science.com
Link to this page from
Twitter DeliciousDiggRedditLinkedIn